U.S. Biotech Stock News

NYSE:RSI
NYSE:RSIHospitality

Rush Street Interactive (RSI) Profitability Shift Tests Bullish Earnings Narratives

Rush Street Interactive (RSI) closed FY 2025 with Q4 revenue of US$324.9 million and basic EPS of US$0.05, alongside net income of US$5.2 million, rounding out a year in which trailing twelve month revenue reached about US$1.1 billion and EPS came in at US$0.32. The company has seen quarterly revenue move from US$232.1 million in Q3 2024 to US$324.9 million in Q4 2025, while basic EPS shifted from US$0.01 to US$0.05 over the same stretch. This sets up a story that now hinges on how...
NasdaqGS:CHDN
NasdaqGS:CHDNHospitality

The Bull Case For Churchill Downs (CHDN) Could Change Following HISA Fee Dispute And Betting Threat

Churchill Downs recently faced enforcement action from the Horseracing Integrity and Safety Authority over US$2,400,000 in unpaid fees for safety inspections and drug testing services, after more than a year of discussions and ongoing federal court challenges. The dispute raises the prospect that HISA could halt out-of-state betting at Churchill Downs and three affiliated tracks, introducing fresh operational and regulatory uncertainty for a business that remains heavily tied to horse...
NYSE:PHM
NYSE:PHMConsumer Durables

New PulteGroup Director Brings Capital Markets Focus To Premium Valuation Context

PulteGroup (NYSE:PHM) has appointed Kristin Gannon as a new independent director to its Board. Gannon brings extensive real estate investment banking and strategic advisory experience to the company. The appointment adds capital markets and transaction expertise to PulteGroup's existing leadership. PulteGroup, trading at $142.1, has experienced substantial longer term share price moves, including a 36.6% return over the past year and a 218.0% return over the past 5 years. Over shorter...
NYSE:BA
NYSE:BAAerospace & Defense

Is Boeing (BA) Pricing In Recent Safety Headlines At US$238 After 1-Year Rally

If you are wondering whether Boeing's current share price lines up with its underlying value, this article will walk through what the numbers actually say and how to read them. Over the short term, the stock has moved 1.1% over the last 7 days and shows a 3.5% decline over 30 days, while the year to date return is 4.9% and the 1 year return sits at 28.4%, with 3 year and 5 year returns of 16.1% and 4.2% respectively. Recent headlines for Boeing have focused on operational and safety issues...
NasdaqGS:MCW
NasdaqGS:MCWConsumer Services

Mister Car Wash (MCW) Earnings Growth And 8.8% Margin Test Bullish Expansion Narratives

Mister Car Wash (MCW) has rounded out its FY 2025 reporting with Q3 revenue of US$263.4 million and basic EPS of US$0.08, set against trailing twelve month revenue of US$1.0 billion and EPS of US$0.28 that reflect an earnings growth rate of 25.5% over the past year. The company has seen quarterly revenue move from US$251.2 million in Q4 2024 to US$265.4 million in Q2 2025 before landing at US$263.4 million in Q3 2025. Basic EPS shifted from US$0.03 in Q4 2024 to around US$0.08 in each of the...
NYSE:HL
NYSE:HLMetals and Mining

Hecla Refocuses On Silver As Casa Berardi Sale Resets Valuation Debate

Hecla Mining (NYSE:HL) has agreed to sell its Casa Berardi gold mine to concentrate on its core silver operations. The company reported record 2025 financial results, with revenue and net income at all time highs. Hecla nearly doubled its exploration and development budget, with a focus on growing silver output, particularly from projects in Nevada. For investors watching Hecla Mining at a share price of $22.02, this shift comes after substantial longer term share gains, including a 16.7%...
NasdaqGS:ITIC
NasdaqGS:ITICInsurance

Investors Title (ITIC) Margin Improvement Tests Long Term Earnings Decline Narrative

Investors Title (ITIC) just wrapped up FY 2025 with fourth quarter total revenue of US$69.5 million and basic EPS of US$3.98, alongside trailing 12 month EPS of US$19.10 on total revenue of US$273.9 million. The company has seen total revenue move from US$258.1 million and EPS of US$16.48 over the trailing 12 months to Q4 2024 to the latest trailing figures. Quarterly revenue has ranged between US$56.6 million and US$73.6 million and quarterly EPS between US$1.68 and US$6.51 across FY 2025,...
NasdaqGS:KMB
NasdaqGS:KMBHousehold Products

Is Kimberly Clark (KMB) Pricing Reflect Its Recent Share Performance And Cash Flow Outlook

If you are wondering whether Kimberly-Clark is attractively priced at its recent levels, looking at how its current share price lines up against different valuation measures can help frame that question clearly. The stock last closed at US$109.90, with returns of 2.1% over the past week, 10.7% over the past month and 8.4% year to date. The 1-year return sits at a 17.1% decline, and the 3- and 5-year returns are 4.2% and 0.9% respectively. Recent coverage has focused on Kimberly-Clark's...
NYSE:AA
NYSE:AAMetals and Mining

Alcoa’s Long Term WA Deal Recasts Environmental Risk And Growth Outlook

Alcoa and the Australian Federal Government have agreed to modernize environmental approvals for the company’s Western Australia mining operations. The package includes strategic environmental assessments through 2045, updated oversight of mining activities, and enforceable undertakings after unauthorized land clearing. Alcoa has committed significant funding to long term forest rehabilitation as part of the agreement. For investors watching NYSE:AA, this agreement sits alongside a share...
NYSE:WFC
NYSE:WFCBanks

Does Wells Fargo’s New Bond Deals And Preferred Payouts Shift Its Funding Story For WFC?

In February 2026, Wells Fargo announced and completed several fixed‑rate, callable senior unsecured note offerings maturing between 2029 and 2046, while also declaring quarterly cash dividends on six series of preferred stock payable in March to holders of record in late February. Together with a class‑action settlement over pandemic‑era credit reporting and higher CEO pay after regulators eased growth constraints, these moves highlight how Wells Fargo is simultaneously managing funding...
NasdaqGM:STHO
NasdaqGM:STHOReal Estate

Star Holdings (STHO) Swings To US$1.8 Million Profit Challenging Persistent Loss Narratives

Star Holdings (STHO) just posted its FY 2025 third quarter numbers with total revenue of US$28.1 million, Basic EPS of US$0.14 and net income of US$1.8 million, setting a very different tone from some of its recent results. The company has seen quarterly revenue move between US$24.6 million and US$42.1 million over the past six reported periods, while Basic EPS has shifted from a gain of US$6.90 to a loss of US$7.70. This latest print therefore fits into a volatile earnings track record that...
NasdaqGS:NEOG
NasdaqGS:NEOGMedical Equipment

Does Neogen’s Food Safety Beat And Insider Buying Strengthen Its Long-Term Case For NEOG?

In the past few days, Neogen reported stronger-than-expected second-quarter fiscal 2026 results, with its Food Safety segment driving the outperformance, while CEO Nassif Mikheal disclosed purchasing 23 additional shares, bringing his indirect holding to 704 shares. This combination of operational strength in core food safety diagnostics and incremental insider accumulation offers investors fresh context on how management and the business are aligned. Next, we'll examine how this Food...
NasdaqCM:ONDS
NasdaqCM:ONDSCommunications

Ondas Weighs Landmark Security Contracts Against Rising JCapital Research Scrutiny

Ondas (NasdaqCM:ONDS) has secured multi year demining contracts along the Israel Syria border that are described as historic in scale for the region. The company is rolling out counter drone solutions with German State Police and entering the handheld C UAS market. These developments arrive as JCapital Research publishes a critical report questioning Ondas' business model and acquisition strategy. For investors tracking Ondas at a share price of $11.07, the stock has seen very large 1 year...
NYSE:ICL
NYSE:ICLChemicals

ICL Group (NYSE:ICL) Net Margin At 5.2% Tests Valuation Narratives Ahead Of Results

ICL Group (NYSE:ICL) has posted another steady quarter, with Q3 FY 2025 revenue of US$1.9 billion and basic EPS of US$0.09, supported by net income of US$115 million. Over the past few quarters, the company has seen revenue move from US$1.6 billion in Q4 FY 2024 to US$1.8 billion in Q2 FY 2025 and US$1.9 billion in Q3 FY 2025. Quarterly EPS has ranged between US$0.05 and US$0.09, setting up a results season in which investors are likely to focus closely on how resilient margins look from...
NasdaqGM:PRE
NasdaqGM:PREHealthcare

Prenetics Global (PRE) Quarterly Loss Narrows To US$5.5 Million Challenging Bearish Narratives

Prenetics Global (NasdaqGM:PRE) has just posted its FY 2025 third quarter numbers, with revenue of US$23.6 million and a basic EPS loss of US$0.40, keeping the company in loss-making territory. The company’s quarterly revenue has moved from US$10.5 million in Q4 2024 to US$17.3 million in Q1 2025, US$15.0 million in Q2 2025 and now US$23.6 million in Q3 2025. Over the same period, EPS losses have shifted from US$1.28 to US$0.80, US$0.64 and US$0.40. Investors are likely to weigh these results...
NYSE:MDT
NYSE:MDTMedical Equipment

Assessing Medtronic’s Valuation After Q3 2026 Beat And Ongoing Robotics And Cardiovascular Momentum

Medtronic (MDT) just released its Q3 2026 results, reporting revenue ahead of expectations and solid contributions from its cardiovascular and diabetes businesses. Management also reaffirmed full year guidance, even as costs and tariffs remain a headwind. See our latest analysis for Medtronic. Medtronic’s share price has been choppy in recent months, with a 2.16% 1 day share price gain after the Q3 release, but only a 1.79% 30 day share price return and a 0.87% 90 day share price decline. Its...
NYSE:HUN
NYSE:HUNChemicals

Huntsman (HUN) Loss-Making Quarter Extends Profitability Debate For Bulls And Bears

Huntsman (HUN) closed FY 2025 with fourth quarter revenue of US$1,355 million and a basic EPS loss of US$0.51, as the business continued to operate in the red on a trailing 12 month basis with EPS at a loss of US$1.59. Over the past six reported quarters, revenue has ranged between US$1,355 million and US$1,540 million, while basic EPS has stayed negative in every period. This highlights how top line stability has not yet translated into earnings stability. With analysts focused on a...
NasdaqGS:EQPT
NasdaqGS:EQPTTrade Distributors

Wall Street Backs EquipmentShare IPO Story With Growth And Valuation Upside

Wall Street brokerages have started coverage of EquipmentShare.com after its recent IPO, focusing on the company’s technology driven rental model. Analysts are highlighting EquipmentShare’s plans to expand its rental footprint and its capital light approach to fleet growth. The new coverage is drawing attention to the company’s goal of doubling rental locations and its position in the equipment rental industry. EquipmentShare.com, listed on NasdaqGS:EQPT, is coming onto more investors’...
NYSE:RVTY
NYSE:RVTYLife Sciences

Is Revvity (RVTY) Now Offering Value After Recent Share Price Weakness

If you are wondering whether Revvity at around US$97.74 is offering good value or just fair value, you are in the right place to unpack what the market might be pricing in. The stock has seen a 3.3% decline over the last 7 days, 13.1% over the last 30 days, and sits around a 0.4% year to date decline and a 14.8% decline over the past year. These moves can change how investors think about its growth potential and risk. Recent coverage of Revvity has focused on its role in the pharmaceuticals...
NYSE:IQV
NYSE:IQVLife Sciences

IQVIA (IQV) EPS Surge To US$3.02 Tests Bearish Margin Concerns

IQVIA Holdings (IQV) just closed out FY 2025 with Q4 revenue of US$4.4b and basic EPS of US$3.02, capping a year in which trailing 12 month revenue came in at US$16.3b and EPS reached US$7.91. Over the past few quarters, the company has seen revenue move from US$3.8b in Q1 2025 to US$4.1b in Q3 2025 and US$4.4b in Q4 2025. Quarterly EPS went from US$1.42 to US$1.94 to US$3.02, setting the stage for investors to weigh that earnings trajectory against an 8.3% net margin that sits below last...
NYSE:UAA
NYSE:UAALuxury

Why Under Armour (UAA) Is Up 12.6% After Deeper Loss Outlook And Final Curry 13 Launch

Under Armour reported past third-quarter 2025 results with sales of US$1,327.76 million and a net loss of US$430.83 million, and issued guidance for a full-year revenue decline of about 4% and a larger operating loss alongside no share repurchases in the latest quarter. At the same time, Under Armour marked the end of its long-running Stephen Curry partnership by launching the Curry 13, a final signature basketball shoe that underscores both the cultural impact of the collaboration and the...
NYSE:CCL
NYSE:CCLHospitality

Carnival Links Food Waste Cuts And Decarbonization To Fleet Performance

Carnival Corporation (NYSE:CCL) is expanding its Less Left Over food waste reduction program through a partnership with OLIO across P&O Cruises, redistributing surplus food to local families. The company reports that thousands of meals have been repurposed so far under this initiative. Carnival has also entered a global service agreement with Evac Group to support preventive maintenance and lifecycle services for environmental systems across its eight cruise lines. The Evac Group agreement...
NasdaqGS:ACLS
NasdaqGS:ACLSSemiconductor

Axcelis Technologies (ACLS) Margin Compression Tests Bullish Silicon Carbide Growth Narrative

Axcelis Technologies (ACLS) just wrapped up FY 2025 with Q4 revenue of US$238.3 million and basic EPS of US$1.11, alongside trailing twelve month revenue of US$839.0 million and EPS of US$3.81 that frame the latest quarter in a fuller earnings picture. Over recent periods, the company has seen quarterly revenue range from US$192.6 million to US$238.3 million and quarterly EPS move between US$0.83 and US$1.11. During the same time, trailing twelve month revenue moved from US$958.1 million to...
NasdaqGM:TNDM
NasdaqGM:TNDMMedical Equipment

Assessing Tandem Diabetes Care (TNDM) Valuation After Recent Share Price Uptick And Ongoing Mixed Returns

Tandem Diabetes Care (TNDM) shares finished the latest session at US$18.94, drawing attention after a period of mixed returns, including negative moves over the past month, past 3 months, year, and longer horizons. See our latest analysis for Tandem Diabetes Care. That 0.5% 1 day share price gain to US$18.94 sits against a softer backdrop, with a 30 day share price return of 6.1% and a 1 year total shareholder return decline of 40.3%, which suggests recent momentum is still fading as...